Skip to content
PubMed This is a summary of 86 peer-reviewed journal articles Updated
Gynecology

Vulvovaginal Candidiasis (Yeast Infection): A Patient Guide

At a Glance

Vulvovaginal candidiasis can cause itching, burning, swelling, and discharge, but other conditions can look similar. A clinician can confirm the cause with testing and choose treatment based on the Candida species, recurrence, and pregnancy status.

Vulvovaginal candidiasis, commonly known as a yeast infection, is a condition where the delicate balance of the vaginal environment shifts, allowing the fungus Candida to overgrow. While this fungus often lives harmlessly as a resident in the body without causing any trouble, certain triggers can cause it to change its physical form. When a species like Candida albicans transforms from a simple yeast cell into long, branch-like structures called hyphae, it begins to interact with the vaginal tissue [1][2].

The intense itching, burning, and swelling most people associate with a yeast infection reflect both the yeast’s presence and a powerful inflammatory response from your own immune system. When the hyphae of C. albicans secrete certain factors, your body sends in specialized white blood cells to defend the area, and it is this inflammatory response that contributes to the physical discomfort you feel [3][4]. Because these symptoms of inflammation—like redness and unusual discharge—are shared by many other conditions, such as bacterial vaginosis, sexually transmitted infections, or skin irritation, relying on symptoms alone can often lead to a mistaken diagnosis [5][6].

When to Seek Care Promptly: Not all vaginal symptoms are simple yeast infections. Seek medical evaluation promptly if you experience fever, lower-abdominal or pelvic pain, foul-smelling or bloody discharge, genital sores or blisters, symptoms while pregnant or immunocompromised, or if your symptoms worsen after trying an over-the-counter cream.

Getting an accurate diagnosis through professional testing is the most important step in finding relief. This process often involves checking the acidity of the vaginal environment and using a microscope, validated molecular test, or a laboratory culture to identify the specific type of yeast involved [7]. This precision matters because different species of yeast (such as Candida glabrata, which typically does not form hyphae) may require different medications, and treating a “look-alike” condition with yeast medication will not resolve the underlying problem [8][9].

Once a diagnosis is confirmed, the approach to care depends on your specific situation. Most occasional, acute infections respond well to short courses of medication, while recurrent infections—those that happen several times a year—require a much more structured, long-term management plan under clinician supervision to keep symptoms at bay [7][10]. Special care is also taken during pregnancy, where the focus shifts toward using gentle, localized treatments that have been proven safe for both the patient and the developing fetus [11]. By working closely with your care team to confirm the cause of your symptoms, you can move away from the frustration of recurring discomfort and toward a treatment plan that truly works for you.

Common questions in this guide

How can I tell whether I have a vaginal yeast infection?
Itching, burning, swelling, redness, and unusual discharge can occur with a yeast infection, but they can also be caused by bacterial vaginosis, sexually transmitted infections, or skin irritation. A clinician may use vaginal pH testing, microscopy, a molecular test, or a culture to confirm the cause.
What tests are used to diagnose vulvovaginal candidiasis?
A clinician may check the acidity of the vaginal environment and examine a sample under a microscope. If needed, a molecular test or laboratory culture can identify Candida and determine which species is present.
Why might yeast infection treatment not work?
Symptoms may be caused by another condition, or by a Candida species such as Candida glabrata that may need a different medication. If symptoms persist, worsen, or return after an over-the-counter treatment, seek follow-up care and ask whether additional testing is needed.
What is the safest yeast infection treatment during pregnancy?
During pregnancy, treatment should be selected with a clinician and should focus on localized options shown to be safe for the pregnant patient and developing fetus. Ask a healthcare professional before using an over-the-counter or prescription treatment.
What happens if I keep getting yeast infections?
Infections that recur several times a year need confirmation and a structured, long-term plan supervised by a clinician. The plan may depend on the Candida species and whether another condition is causing the symptoms.
When should vaginal symptoms be checked promptly?
Seek prompt medical evaluation for fever, lower-abdominal or pelvic pain, foul-smelling or bloody discharge, genital sores or blisters, symptoms during pregnancy or while immunocompromised, or symptoms that worsen after an over-the-counter cream.

Get notified when new evidence is published on vulvovaginal candidiasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset.

    Ardizzoni A, Wheeler RT, Pericolini E

    Frontiers in microbiology 2021; (12()):692491 doi:10.3389/fmicb.2021.692491.

    PMID: 34163460
  2. 2

    A Role for Yeast/Pseudohyphal Cells of Candida albicans in the Correlated Expression of NLRP3 Inflammasome Inducers in Women With Acute Vulvovaginal Candidiasis.

    Roselletti E, Monari C, Sabbatini S, et al.

    Frontiers in microbiology 2019; (10()):2669 doi:10.3389/fmicb.2019.02669.

    PMID: 31803172
  3. 3

    Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence.

    Richardson JP, Mogavero S, Moyes DL, et al.

    mBio 2018; (9(1)) doi:10.1128/mBio.02178-17.

    PMID: 29362237
  4. 4

    Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.

    Richardson JP, Willems HME, Moyes DL, et al.

    Infection and immunity 2018; (86(2)) doi:10.1128/IAI.00645-17.

    PMID: 29109176
  5. 5

    Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.

    Schwebke JR, Taylor SN, Ackerman R, et al.

    Journal of clinical microbiology 2020; (58(2)) doi:10.1128/JCM.01643-19.

    PMID: 31748322
  6. 6

    Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

    Pereira LC, Correia AF, da Silva ZDL, et al.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2021; (40(8)):1681-1693 doi:10.1007/s10096-021-04199-1.

    PMID: 33713006
  7. 7

    Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.

    Nyirjesy P, Brookhart C, Lazenby G, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(Suppl_2)):S162-S168 doi:10.1093/cid/ciab1057.

    PMID: 35416967
  8. 8

    Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management.

    Yan Z, Cui Y, Li Y, et al.

    Frontiers in microbiology 2026; (17()):1944046 doi:10.3389/fmicb.2026.1944046.

    PMID: 42780976
  9. 9

    Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.

    Dunaiski CM, Kock MM, Chan WY, et al.

    Medical mycology 2024; (62(2)) doi:10.1093/mmy/myae009.

    PMID: 38308518
  10. 10

    Recurrent vulvovaginal candidiasis: A review of guideline recommendations.

    Matheson A, Mazza D

    The Australian & New Zealand journal of obstetrics & gynaecology 2017; (57(2)):139-145 doi:10.1111/ajo.12592.

    PMID: 28299777
  11. 11

    Vulvovaginal candidiasis in pregnancy.

    Aguin TJ, Sobel JD

    Current infectious disease reports 2015; (17(6)):462 doi:10.1007/s11908-015-0462-0.

    PMID: 25916994

This page is for informational purposes only and is not medical advice. A clinician should confirm the cause of your symptoms and recommend the safest treatment for your situation, especially during pregnancy or if you are immunocompromised.